Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
There is evidence that major psychiatric discords such as schizophrenia (SZ) and bipolar disorder (BD) are associated with dysregulation of synaptic plasticity with downstream alterations of neurotrophins. Brain-derived neurotrophic factor (BDNF) is the most widely distributed neurotrophin in the central nervous system (CNS), and performs many biological functions such as promoting the survival, differentiation, and plasticity of neurons. Variants in the BDNF gene increase the risk of SZ and bipolar disorder. Chronic administration of drugs used to treat SZ and BD, such as lithium, valproate, quetiapine, clozapine, and olanzapine, increases BDNF expression in rat brain. To examine serum BDNF, three groups of chronically medicated DSM-IV SZ patients, on treatment with clozapine (n=27), typical (n=14), and other atypical antipsychotics (n=19), 30 euthymic BD patients, and 26 healthy control had 5 ml blood samples collected by venipuncture. Serum BDNF levels were significantly higher in SZ patients (p<0.001) when compared to either controls or euthymic BD patients. Increased BDNF in SZ patients might be related to the course of illness or to treatment variables. Prospective studies are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
McGuffin, P. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810320088015 · Cited by 1,483
Castrén, E. (2005) · Nature Reviews Neuroscience · doi:10.1038/nrn1629 · Cited by 563
Belmaker, R. H. (2004) · New England Journal of Medicine · doi:10.1056/nejmra035354 · Cited by 473
Gratacòs, M., González, J. R., Mercader, J. M., de Cid, R., Urretavizcaya, M., & Estivill, X. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.025 · Cited by 428
The functional neuroanatomy of mood disorders
Soares, J. C., & Mann, J. J. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(97)00016-2 · Cited by 379
Research works printed but not linked: 26
- Azevedo, 1999, Using consensus OPCRIT diagnoses – an efficient procedure for best-estimate lifetime diagnoses, Br. J. Psychiatry, 175, 154, 10.1192/bjp.175.2.154 · DOI · Paper page
- Bai, 2003, Expression of brain-derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs, J. Neurosci. Res., 71, 127, 10.1002/jnr.10440 · DOI · Paper page
- Chen, 2006, Association between the brain-derived neurotrophic factor (BDNF) gene and schizophrenia in the Chinese population, Neurosci. Lett., 397, 285, 10.1016/j.neulet.2005.12.033 · DOI
- Coyle, 2003, Finding the intracellular signaling pathways affected by mood disorder treatments, Neuron., 38, 157, 10.1016/S0896-6273(03)00195-8 · DOI · Paper page
- Craddock, 1996, Concurrent validity of the OPCRIT diagnostic system – comparison of OPCRIT diagnoses with consensus best-estimate lifetime diagnoses, Br. J. Psychiatry, 169, 58, 10.1192/bjp.169.1.58 · DOI · Paper page
- Cunha, 2006, Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes, Neurosci. Lett., 398, 215, 10.1016/j.neulet.2005.12.085 · DOI · Paper page
- Frey, 2006, Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania, Life Sci., 79, 281, 10.1016/j.lfs.2006.01.002 · DOI · Paper page
- Fukumoto, 2001, Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain, Psychopharmacology (Berl), 158, 100, 10.1007/s002130100871 · DOI · Paper page
- Gama, 2006, Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine, Prog. Neuropsychopharmacol. Biol. Psychiatry, 30, 512, 10.1016/j.pnpbp.2005.11.009 · DOI · Paper page
- Grillo, 2007, Reduced serum BDNF levels in schizophrenic patients on clozapine or typical antipsychotics, J. Psychiatr. Res., 41, 31, 10.1016/j.jpsychires.2006.01.005 · DOI · Paper page
- Hamilton, 1960, A rating scale for depression, J. Neurol. Neurosurg. Psychiatry, 23, 56, 10.1136/jnnp.23.1.56 · DOI · Paper page
- Jockers-Scherubl, 2004, Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse, Neurosci. Lett., 371, 79, 10.1016/j.neulet.2004.08.045 · DOI
- Jonsson, 2006, Brain-derived neurotrophic factor gene (BDNF) variants and schizophrenia: an association study, Prog. Neuropsychopharmacol. Biol. Psychiatry, 30, 924, 10.1016/j.pnpbp.2006.02.008 · DOI
- Lieberman, 1999, Pathophysiologic mechanisms in the pathogenesis and clinical course of schizophrenia, J. Clin. Psychiatry, 60, 9
- Lohoff, 2005, Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder, Am. J. Med. Genet. B Neuropsychiatr. Genet., 139, 51, 10.1002/ajmg.b.30215 · DOI · Paper page
- Machado-Vieira, 2007, Decreased plasma brain derived neurotrophic factor levels in unmedicated bipolar patients during manic episode, Biol. Psychiatry, 61, 142, 10.1016/j.biopsych.2006.03.070 · DOI · Paper page
- Mahadik, 2006, Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia, Int. Rev. Psychiatry, 18, 119, 10.1080/09540260600581993 · DOI · Paper page
- Neves-Pereira, 2002, The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study, Am. J. Hum. Genet., 71, 651, 10.1086/342288 · DOI · Paper page
- Park, 2006, Effects of quetiapine on the brain-derived neurotrophic factor expression in the hippocampus and neocortex of rats, Neurosci. Lett., 402, 25, 10.1016/j.neulet.2006.03.028 · DOI
- Palomino, 2006, Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients, Schizophr. Res., 86, 321, 10.1016/j.schres.2006.05.028 · DOI · Paper page
- Qian, 2007, Brain-derived neurotrophic factor and risk of schizophrenia: an association study and meta-analysis, Biochem. Biophys. Res. Commun., 353, 738, 10.1016/j.bbrc.2006.12.121 · DOI
- Rybakowski, 2003, Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients, Bipolar Disord., 5, 468, 10.1046/j.1399-5618.2003.00071.x · DOI · Paper page
- Rybakowski, 2006, Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene, Psychiatry Clin. Neurosci., 60, 70, 10.1111/j.1440-1819.2006.01462.x · DOI · Paper page
- Strakowski, 2005, Abnormal FMRI brain activation in euthymic bipolar disorder patients during a counting Stroop interference task, Am. J. Psychiatry, 162, 1697, 10.1176/appi.ajp.162.9.1697 · DOI · Paper page
- Tan, 2005, Decreased BDNF in serum of patients with chronic schizophrenia on long-term treatment with antipsychotics, Neurosci. Lett., 382, 27, 10.1016/j.neulet.2005.02.054 · DOI
- Tan, 2005, Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements, Schizophr. Res., 74, 263, 10.1016/j.schres.2004.08.004 · DOI
Cited by
Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis
Green, M. J., Matheson, S. L., Shepherd, A., Weickert, C. S., & Carr, V. J. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.88 · Cited by 453
Fernandes, B. S., Gama, C. S., Maria Ceresér, K., Yatham, L. N., Fries, G. R., Colpo, G., de Lucena, D., Kunz, M., Gomes, F. A., & Kapczinski, F. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.03.002 · Cited by 389
Self-citationDomenici, E., Willé, D. R., Tozzi, F., Prokopenko, I., Miller, S., McKeown, A., Brittain, C., Rujescu, D., Giegling, I., Turck, C. W., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009166 · Cited by 347
Scalzo, P., Kümmer, A., Bretas, T. L., Cardoso, F., & Teixeira, A. L. (2010) · Journal of Neurology · doi:10.1007/s00415-009-5357-2 · Cited by 299
“Altered BDNF levels have also been described in several neurological and psychiatric disorders including Alzheimer’s disease [3, 24], Huntington’s disease [4], major depression [25], bipolar disorder [26] and schizophrenia [26, 27].”
BackgroundResultReview of Lithium Effects on Brain and Blood
Young, W. (2009) · Cell Transplantation · doi:10.3727/096368909x471251 · Cited by 287
Metadata
- Authors
- Gama, C. S., Andreazza, A. C., Kunz, M., Berk, M., Belmonte-de-Abreu, P. S., & Kapczinski, F.
- Venue
- Neuroscience Letters
- Publisher
- Elsevier BV
- Published
- 2007-06
- Volume
- 420
- Issue
- 1
- Pages
- 45-48
- ISSN
- 0304-3940 (ISSN-L)
- OpenAlex
- W2039636801
- Cited by
- 153
- References
- 6
- FWCI
- 8.37
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. https://app.cochat.ai/papers/10.1016/j.neulet.2007.04.001
- The paper
- Gama, C. S., Andreazza, A. C., Kunz, M., Berk, M., Belmonte-de-Abreu, P. S., & Kapczinski, F. (2007). Serum levels of brain-derived neurotrophic factor in patients with schizophrenia and bipolar disorder. Neuroscience Letters. https://doi.org/10.1016/j.neulet.2007.04.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.